New Podcast: the value of Mitomycin Maintenance Therapy in IR NMIBC*
Urologist Dr. Marco Moschini from San Raffaele University Milan, Italy, talks in this 15-minute-podcast about the treatment of intermediate-risk non-muscle-invasive bladder cancer (NMIBC).
Events and congresses
medac GmbH supports hybrid symposium on optimizing outcomes for patients with NMIBC at EAU congress
Join the symposium on April 6th , 2 PM CEST.
Events and congresses
medac returns as official sponsor at the EAU congress in Paris
Visit us at booth D42 from April 5th to April 8th 2024.
Events and congresses
medac is mastering the wave - and brings a bright perspective to patients with bladder cancer
New brand identity for medac´s immunotherapeutic product.
